SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950142-22-003351
Filing Date
2022-12-13
Accepted
2022-12-13 17:00:52
Documents
2
Period of Report
2022-12-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es220312564_3-tuch.html 3  
1 OWNERSHIP DOCUMENT es220312564_3-tuch.xml 3 1618
2 EXHIBIT 24 es220312564_3-ex24.htm EX-24 7365
  Complete submission text file 0000950142-22-003351.txt   10476
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Issuer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O VTV THERAPEUTICS INC. 3980 PREMIER DRIVE HIGH POINT NC 27265
Business Address
Tuch Steven L. (Reporting) CIK: 0001957337 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37524 | Film No.: 221460322